Exact Mass: 305.0164
Exact Mass Matches: 305.0164
Found 174 metabolites which its exact mass value is equals to given mass value 305.0164
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Cyclic cmp
Acquisition and generation of the data is financially supported in part by CREST/JST.
Cytidine 2',3'-cyclic phosphate
Acyclovir monophosphate
D000890 - Anti-Infective Agents > D000998 - Antiviral Agents
3-((5-(2,3-Dichlorophenyl)-1H-tetrazol-1-yl)methyl)pyridine
Acyclovir monophosphate
Cifostodine
2-Aminomethyl-4-t-butyl-6-iodophenol
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D002317 - Cardiovascular Agents > D045283 - Natriuretic Agents D045283 - Natriuretic Agents > D004232 - Diuretics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents
5-[(E)-(6-Bromo-1H-indole-3-yl)methylene]imidazolidine-2,4-dione
2,3 Cyclic CMP
Sodium risedronate
C78281 - Agent Affecting Musculoskeletal System > C67439 - Bone Resorption Inhibitor D050071 - Bone Density Conservation Agents > D004164 - Diphosphonates D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
2-(1,3-benzoxazol-2-yl)-1-[4-(trifluoromethyl)phenyl]ethanone
2-(1,3-benzoxazol-2-yl)-1-[3-(trifluoromethyl)phenyl]ethanone
5-Chloro-2-methyl-3-(3-sulfopropyl)benzothiazolium,inner salt
2-Methyl-2-propanyl (2-bromo-4-chlorophenyl)carbamate
2-[5-(3,4-dichlorophenyl)-1,3,4-oxadiazol-2-yl]aniline
tert-butyl N-[2-(2,4-dichlorophenyl)-2-hydroxyethyl]carbamate
2-([(4-CHLOROPHENYL)SULFONYL]AMINO)-4-METHYLPENTANOIC ACID
4-(2-PYRIDINYLOXY)BENZENESULFONYLCHLORIDEHYDROCHLORIDE
ETHYL 3-(5-BROMO-2-METHYL-4-NITRO-1H-IMIDAZOL-1-YL)PROPANOATE
4-(3-chloro-2-fluoroanilino)-6-hydroxy-1H-quinazolin-7-one
isopropyl N-[chloro(phenoxy)phosphoryl]-L-alaninate
4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole-5-carbonyl chloride
tert-Butyl 3-(2-bromoacetyl)piperidine-1-carboxylate
ethyl 4-chloro-5-(ethoxycarbonyloxy)-2-fluorophenylcarbamate
6-bromo-3-chloro-N-(oxan-4-ylmethyl)pyrazin-2-amine
7-BROMO-1,2,3,4-TETRAHYDRO-ACRIDINE-9-CARBOXYLICACID
2-(4-methoxy-phenyl)-imidazo[1,2-a]pyrimidine monohydrobromine
ETHYL 2-[(4,5-DICHLORO-1H-IMIDAZOL-1-YL)METHYL]-1,3-THIAZOLE-4-CARBOXYLATE
3-chloro-5-cyclopropyl-7-(trifluoromethyl)pyrazolo[1,5-a]pyrimidine-2-carboxylic acid
4-CHLORO-1-(4-METHOXYBENZYL)-1H-IMIDAZO[4,5-C]PYRIDINE-2(3H)-THIONE
ETHYL 2-CHLORO-2-(2-(4-CHLORO-2-NITROPHENYL)HYDRAZONO)ACETATE
3-(6-Bromopyridin-2-yl)-4-methyl-benzoic acid methyl ester
N-[4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-ylidene]hydroxylamine
[2-(5-BROMO-THIOPHEN-2-YL)-ETHYL]-CARBAMIC ACID TERT-BUTYL ESTER
3-(2-Amino-4-pyrimidinyl)-6-bromo-1H-pyrrolo[2,3-b]pyridin-4-ol
4-CYANO-3-(4-METHOXYPHENYL)-5-(METHYLTHIO)THIOPHENE-2-CARBOXYLIC ACID
4-(Pyridin-3-yloxy)benzene-1-sulfonyl chloride hydrochloride
(4-cyano-3,5-difluorophenyl) 4-ethyl-2-fluorobenzoate
2-(4-FLUOROPHENYL)-2-HYDROXY-4,4-DIMETHYL-1,4-OXAZINAN-4-IUM BROMIDE
(2-(2-FLUORO-4-(TRIFLUOROMETHYL)PHENYL)-4-METHYLTHIAZOL-5-YL)METHANOL
9-Bromo-2,3,5,6,13,13a-hexahydro-1H-benzo[4,5]imidazo[1,2-d]pyrrolo[1,2-a][1,4]diazepine
(s)-3-amino-4-pentafluorophenylbutanoic acid hydrochloride
(r)-3-amino-4-pentafluorophenylbutanoic acid hydrochloride
1-Chloro-4-[Isocyano[(4-Methylphenyl)Sulfonyl]Methyl]-Benzene
5-Bromo-2-(3-methyl-5-(trifluoromethyl)-1H-pyrazol-1-yl)pyridine
2-Bromo-6-(3-methyl-5-(trifluoromethyl)-1H-pyrazol-1-yl)pyridine
2-[2-(4-Bromophenoxy)ethyl]-5-ethylpyridine Hydrogen Sulfate Salt
tert-butyl 4-(1-bromo-2-oxoethyl)piperidine-1-carboxylate
6-(3-CHLORO-4-FLUOROPHENYL)-4,4-DIMETHYL-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE
6-(3-CHLORO-5-FLUOROPHENYL)-4,4-DIMETHYL-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE
2-Chloro-3-methyl-4-[(7R,7AS)-tetrahydro-7-hydroxy-1,3-dioxo-1H-pyrrolo[1,2-c]imidazol-2(3H)-yl]benzonitrile
2,3-cyclic UMP(1-)
A 2,3-cyclic nucleotide(1-) which is obtained from 2,3-cyclic UMP by removal of a proton from the cyclic phosphate group.
N-[[[oxo(thiophen-2-yl)methyl]hydrazo]-sulfanylidenemethyl]benzamide
5-((5-(4-Fluoro-2-hydroxyphenyl)furan-2-yl)methylene)thiazolidine-2,4-dione
5-[(1,3-Benzothiazol-2-ylthio)methyl]-2-furancarboxylic acid methyl ester
N-(4,6-difluoro-1,3-benzothiazol-2-yl)benzohydrazide
2-chloro-N-[4-[(3,4-dimethylphenyl)thio]phenyl]acetamide
9-(2-furyl)-3,4a,5,6,7,8,8a,9-octahydro-2H-5,8-methanothiochromeno[2,3-d][1,3]thiazol-2-one
(Glycolato-O,O)diammineplatinum(II)
D000970 - Antineoplastic Agents
dCMP dianion
COVID info from COVID-19 Disease Map Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
alpha-D-ribose 1-methylphosphonate 5-phosphate(3-)
[(2R,3S,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-yl] phosphate
2-[[[(5-Chloro-2-pyridinyl)amino]-oxomethyl]amino]benzoic acid methyl ester
4-nitro-N-[(thiophen-2-ylacetyl)oxy]benzenecarboximidamide
2-(5-Bromo-2-furanyl)-6-methyl-3,1-benzoxazin-4-one
4-[1-(4-fluorophenyl)ethyl]-3-thiophen-2-yl-1H-1,2,4-triazole-5-thione
1-(3-Methylphenyl)-3-[[(5-methyl-3-thiophenyl)-oxomethyl]amino]thiourea
3-[(2-Chloro-4-fluorophenoxy)methyl]-1,2,3-benzotriazin-4-one
1-(2-Methylphenyl)-3-[[(5-methyl-3-thiophenyl)-oxomethyl]amino]thiourea
N-(3,4-dichlorophenyl)-6-(1-imidazolyl)-3-pyridazinamine
1-methyl-N-[4-(trifluoromethyl)phenyl]-4-imidazolesulfonamide
1-(3,5-Dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one(1-)
A phenolate anion resulting from the removal of a proton from one of the hydroxy groups of 1-(3,5-dichloro-2,6-dihydroxy-4-methoxyphenyl)hexan-1-one (DIF-1). The major structure at pH 7.3.
2-Chloro-10-phenothiazinecarboxylic acid ethyl ester
2-Amino-3-(3-methoxy-4-sulfooxyphenyl)-2-methylpropanoic acid
4-amino-1-[2-hydroxy-6-(hydroxymethyl)-2-oxidotetrahydrofuro[3,4-d][1,3,2]dioxaphosphol-4-yl]pyrimidin-2(1H)-one
2,3-cyclic CMP
A 2,3-cyclic pyrimidine nucleotide in which cytidine is the parent nucleoside.
2-deoxycytosine 5-monophosphate(2-)
A 2-deoxyribonucleoside 5-monophosphate(2-) obtained by deprotonation of the phosphate OH groups of 2-deoxycytidine 5-monophosphate (dCMP); major species at pH 7.3.
Taminadenant
Taminadenant (NIR178; PBF509) is a highly potent and orally active adenosine A2A receptor (A2AR) antagonist. Taminadenant can antagonize A2AR agonist-mediated cAMP accumulation and impedance responses with KB values of 72.8 nM and 8.2 nM, respectively. Taminadenant reverses motor impairments in several rat models of movement disorders, including catalepsy, tremor, and hemiparkinsonism. Taminadenant can also inhibit tumor growth when combined with Spartalizumab (HY-P9972). Taminadenant reactivate the antitumor immune response[1][2].